Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

ABT 43.41 -0.27 (-0.62%)
price chart
Will Abbott Labs (ABT) Disappoint on Earnings This Quarter?
Our proven model does not conclusively show that Abbott Labs is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to likely have earnings beat.
Abbott Laboratories (ABT) Stock Lower Today After Jefferies Downgrade
"We rate ABBOTT LABORATORIES (ABT) a BUY. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover.
Abbott Laboratories Lowered to �Hold� at Jefferies Group  Ticker Report
Abbott Laboratories Stock Rating Lowered by Jefferies Group  The Legacy
Abbot Laboratories (ABT) Stock Gains Today on $5.3 Billion Generic Business ...
NEW YORK (TheStreet) -- Abbott Laboratories (ABT - Get Report) shares are up 0.93% to $44.08 in trading on Wednesday after European regulators approved the purchase of the company's non-U.
EU approves Mylan purchase of Abbot generics, subject to conditions  Reuters
Short Interest of Abbott Laboratories Drops by 6.4%
Abbott Laboratories (NYSE:ABT), A drop of 830,005 shares or 6.4% was seen in the short interest of Abbott Laboratories. Even as the interest dropped from 13,067,926 shares on December 31,2014 to 12,237,921 shares on January 15,2015, the days to cover ...
Abbott Laboratories (ABT) Set to Announce Quarterly Earnings on Thursday  The Legacy
Abbott Laboratories (ABT) Scheduled to Post Earnings on Thursday  Ticker Report
Abbott Labs Is A Healthcare Conglomerate I Used To Be Excited About (ABT)
The last time I analyzed Abbott Laboratories (NYSE:ABT) on December 4, 2014, I stated, "Having done this analysis I don't see anything that is telling me it is a screaming buy right now other than the call buying that took place, hence I'm going to ...
Investors Sell Shares of Abbott Laboratories on Strength (ABT)  Ticker Report
Abbott Laboratories Sees Largest Outflow of Money  Bar and Graph Report
Related articles »  
Ex-Dividend Reminder: AbbVie, Abbott Laboratories and Mid-America ...
Looking at the universe of stocks we cover at Dividend Channel, on 1/13/15, AbbVie Inc. (NYSE: ABBV), Abbott Laboratories (NYSE: ABT), and Mid-America Apartment Communities Inc (NYSE: MAA) will all trade ex-dividend for their respective upcoming ...
Dividend stocks to buy before they trade ex-dividend: Glimcher Realty Trust ...  Wall Street Observer
Research and Markets: Global qPCR and dPCR Market 2015-2019: Abbott ...
This report covers the present scenario and the growth prospects of Global qPCR and dPCR market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of qPCR and dPCR products: qPCR and dPCR ...
Abbott Laboratories facing class action over protein drink
Sara Hawes and Clarice Chavira filed the lawsuit against Abbott Laboratories, alleging the amount of protein in Abbott's EAS Myoplex Original and EAS AdvantEdge Carb Control ready-to-drink protein products didn't contain the amount of protein that was ...
Abbott Labs Increases Dividend But Return On Equity Is Suffering (ABT)
The company increased its dividend by 9.1% but I believe it was better suited to retain that money and invest in something a little less commoditized.
Related articles »  
March 20th Options Now Available For Abbott Laboratories (ABT)
Investors in Abbott Laboratories (Symbol: ABT) saw new options become available today, for the March 20th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the ABT options chain for the new March 20th contracts and ...